Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma

  1. Hiller-Vallina, S.
  2. Mondejar-Ruescas, L.
  3. Caamaño-Moreno, M.
  4. Cómitre-Mariano, B.
  5. Alcivar-López, D.
  6. Sepulveda, J.M.
  7. Hernández-Laín, A.
  8. Pérez-Núñez, Á.
  9. Segura-Collar, B.
  10. Gargini, R.
Journal:
Neuro-Oncology

ISSN: 1523-5866 1522-8517

Year of publication: 2024

Volume: 26

Issue: 7

Pages: 1213-1227

Type: Article

DOI: 10.1093/NEUONC/NOAE033 GOOGLE SCHOLAR lock_openOpen access editor